Revenue Performance - Q4 net revenue was $136.4 million, up 8% sequentially and up 48% year over year[3]. - Fiscal year 2025 net revenue reached $467.6 million, an increase of 30% over fiscal year 2024[7]. - The company expects Q1 2026 net revenue to be approximately $130 million to $140 million[6]. - Net revenue for Q4 2025 reached $136,436,000, a 7.5% increase from $126,459,000 in Q3 2025 and a 48% increase from $92,167,000 in Q4 2024[25]. - For the full year 2025, net revenue increased to $467,641,000, up 29.7% from $360,528,000 in 2024[27]. Profitability Metrics - GAAP gross margin for Q4 was 57.6%, compared to 55.6% in the year-ago quarter[3]. - Non-GAAP gross margin for Q4 was 59.6%, up from 59.1% in the prior quarter[3]. - Non-GAAP diluted earnings per share for Q4 was $0.19, compared to a loss per share of $0.09 in the year-ago quarter[3]. - GAAP gross profit for Q4 2025 was $78,557 thousand, an increase of 53.3% compared to $51,248 thousand in Q4 2024[36]. - Non-GAAP gross profit for Q4 2025 reached $81,345 thousand, up from $54,432 thousand in Q4 2024, reflecting a growth of 49.4%[36]. - Non-GAAP income from operations for Q4 2025 was 16.2%, compared to a loss of 7.5% in Q4 2024[40]. - Non-GAAP net income for Q4 2025 was 12.7%, compared to a loss of 7.8% in Q4 2024[40]. Operating Expenses - GAAP operating expenses for fiscal year 2025 were $392.7 million, down from $418.1 million in fiscal 2024[7]. - Total operating expenses for Q4 2025 were $93,449,000, down from $113,190,000 in Q3 2025, primarily due to a reduction in restructuring charges[25]. - Research and development expenses for the full year 2025 were $208,599,000, a decrease from $225,189,000 in 2024, reflecting a strategic focus on cost management[27]. - Research and development (R&D) expenses for Q4 2025 were $51,691 thousand, slightly lower than $51,278 thousand in Q4 2024[36]. - GAAP SG&A expenses for Q4 2025 were 30.8%, a decrease from 41.3% in Q4 2024[40]. - Non-GAAP SG&A expenses for Q4 2025 were 16.2%, down from 23.5% in Q4 2024[40]. Cash Flow and Financial Position - Cash provided by operating activities for Q4 2025 was $10,406,000, compared to $10,124,000 in Q3 2025, indicating improved cash flow management[30]. - Cash, cash equivalents, and restricted cash at the end of Q4 2025 totaled $101,412,000, down from $113,263,000 at the end of Q3 2025[30]. - Total assets decreased to $796,396 thousand as of December 31, 2025, down from $864,639 thousand a year earlier, representing a decline of approximately 7.9%[34]. - Total liabilities increased slightly to $344,501 thousand as of December 31, 2025, compared to $329,321 thousand a year earlier[34]. - Stockholders' equity decreased to $451,895 thousand as of December 31, 2025, down from $516,283 thousand a year earlier, reflecting a decline of approximately 12.5%[34]. Loss and Recovery - GAAP loss from operations was 11% of net revenue in Q4, significantly improved from 45% in the year-ago quarter[3]. - Non-GAAP income from operations was 16% of net revenue in Q4, compared to a loss of 7% in the year-ago quarter[3]. - The net loss for Q4 2025 was $14,897,000, an improvement from a net loss of $45,485,000 in Q3 2025 and $57,838,000 in Q4 2024[25]. - The net loss for the full year 2025 was $136,681,000, a significant reduction from $245,198,000 in 2024[27]. - Non-GAAP income (loss) from operations for the twelve months ended December 31, 2025, was $43,495 thousand, a recovery from a loss of $68,459 thousand in the previous year[38]. - Non-GAAP basic net income per share for the twelve months ended December 31, 2025, was $0.31, compared to a loss of $0.90 per share in 2024[38].

Visa Reports Fiscal First Quarter 2026 Results San Francisco, CA, January 29, 2026 – Visa (NYSE: V) Income Statement Summary | In billions, except percentages and per share data. % change is calculated over the comparable prior-year period. | USD | % Change | results: | | --- | --- | --- | --- | | Net Revenue | $10.9 | 15% | | | GAAP Net Income | $5.9 | 14% | | | GAAP Earnings Per Share | $3.03 | 17% | | | (1) Non-GAAP Net Income | $6.1 | 12% | | | (1) Non-GAAP Earnings Per Share | $3.17 | 15% | | Key Busin ...

Financial Performance - Revenue for Q4 2025 was $248.2 million, a 22% increase year-over-year from $203.7 million in Q4 2024[15] - Full year revenue for 2025 reached $951 million, a 20% increase from $794 million in 2024[4] - Net income for Q4 2025 was $39,914 thousand, a decrease of 61% compared to $102,734 thousand in Q4 2024[17] - Non-GAAP net income for the twelve months ended December 31, 2025, was $192,046 thousand, up from $160,877 thousand in 2024, reflecting a growth of 19%[20] Operating Income and Margins - GAAP operating income for Q4 2025 was $44 million, representing 17.6% of revenue, compared to $23 million or 11.3% of revenue in Q4 2024[4] - Non-GAAP operating income for Q4 2025 was $62 million, or 24.9% of revenue, up from $41 million or 20.2% in Q4 2024[4] - Full year non-GAAP operating margin is expected to be in the range of 25.5% to 27.5% for fiscal year 2026[4] - Non-GAAP operating margin improved to 24.9% in Q4 2025 from 20.2% in Q4 2024[20] Cash Flow and Assets - Net cash provided by operating activities for Q4 2025 was $65 million, or 26.2% of revenue, compared to $37 million or 18.0% in Q4 2024[4] - Cash provided by operating activities for Q4 2025 was $64,990 thousand, compared to $36,566 thousand in Q4 2024, marking an increase of 78%[17] - Cash and cash equivalents increased to $107 million in 2025 from $42.5 million in 2024[13] - Total assets grew to $689 million in 2025, up from $627 million in 2024[13] Expenses - GAAP cost of revenue for Q4 2025 was $90,540 thousand, up from $76,189 thousand in Q4 2024, indicating a rise of 19%[19] - GAAP sales and marketing expenses for Q4 2025 were $40,159 thousand, up from $33,436 thousand in Q4 2024, reflecting a growth of 20%[19] - Stock-based compensation expense for the twelve months ended December 31, 2025, was $70,790 thousand, compared to $60,328 thousand in 2024, an increase of 17%[20] Future Projections - The company anticipates full year revenue for 2026 to be in the range of $1,100 million to $1,120 million[4] Non-GAAP Financial Measures - The company utilizes non-GAAP financial measures to assess operating performance, which include income from operations, operating margin, and net income per share[22] - Non-GAAP operating margin is calculated as non-GAAP operating income from operations as a percentage of revenue, providing insights into financial performance[22] - The company emphasizes the importance of reconciling non-GAAP financial measures to GAAP measures for a comprehensive understanding of financial results[23] - Investors are encouraged to review reconciliations of historical non-GAAP measures to their GAAP counterparts for better clarity[23] - Non-GAAP financial measures may not be directly comparable to those of other companies in the industry due to different calculation methods[23] - Non-GAAP measures are used for internal budgeting and forecasting, aiding in the evaluation of financial performance across reporting periods[22] Tax Rates and Compliance - The projected long-term non-GAAP tax rates are set at 21% for 2025 and 25% for 2024, based on the company's operating structure and tax positions[24] - The company periodically re-evaluates its projected tax rate based on significant events and changes in tax law[24] - Amortization of purchased intangibles is considered a pre-acquisition expense and does not typically reflect operational performance during specific periods[24] - Stock-based compensation expenses are used to attract and retain employees, aligning their interests with stockholders, but vary independently of operational performance[24]

Financial Performance - Revenue for the second quarter of fiscal year 2026 increased by 11% year-over-year to $1.4 billion, with a 9% increase on a constant currency basis[5]. - Diluted earnings per share for the quarter was $2.68, representing a 15% increase compared to the prior year, while non-GAAP diluted earnings per share increased by 16% to $2.81[5][9]. - Net income for the quarter was $392.6 million, a 14% increase from the previous year[6][9]. - Total revenue for the three months ended December 31, 2025, was $1,422.8 million, an 11% increase compared to $1,282.1 million for the same period in 2024[24]. - For the six months ended December 31, 2025, total revenue was $2,758.4 million, a 10% increase from $2,506.6 million in 2024[24]. Margins and Profitability - Non-GAAP gross margin expanded by 310 basis points to 62.3%, driven by manufacturing efficiencies and component cost improvements[5][9]. - GAAP gross margin improved to 61.8% for the three months ended December 31, 2025, compared to 58.6% in 2024[20]. - Non-GAAP gross profit for the three months ended December 31, 2025, was $886,532, up from $758,909 in 2024, indicating a growth of 17%[20]. Cash Flow and Assets - Operating cash flow for the quarter was $340 million, reflecting strong financial performance[9]. - Cash and cash equivalents at the end of the period were $1,417,069, an increase from $1,209,450 at the beginning of the period, marking a rise of 17%[18]. - Net cash provided by operating activities for the six months ended December 31, 2025, was $797,066, compared to $634,161 in 2024, reflecting a year-over-year increase of 26%[18]. - Total assets increased to $8,503,370, up from $8,174,391, representing a growth of 4%[17]. Shareholder Returns and Capital Management - The company declared a quarterly cash dividend of $0.60 per share, payable on March 19, 2026[8]. - The company repurchased 704,000 shares for $175 million as part of its capital management strategy[9]. Expenses and Investments - Research and development expenses increased by 12% year-over-year, reflecting ongoing investment in innovation[6][9]. Market Performance - Revenue in the U.S., Canada, and Latin America grew by 11%, while revenue in Europe, Asia, and other markets increased by 6% on a constant currency basis[7]. - Total Sleep and Breathing Health revenue reached $1,255.9 million for the three months ended December 31, 2025, up 12% from $1,125.6 million in 2024[24]. - Combined revenue from Europe, Asia, and other markets for the three months ended December 31, 2025, was $420.9 million, a 12% increase from $376.6 million[24]. - Devices revenue in combined Europe, Asia, and other markets was $278.2 million, a 9% increase from $254.8 million[24]. - The company reported a 7% increase in Residential Care Software revenue for the three months ended December 31, 2025, totaling $166.9 million compared to $156.5 million in 2024[24]. - Constant currency measures indicate that the company’s revenue growth is consistent across different markets, excluding foreign currency fluctuations[25]. Debt and Liabilities - Total current liabilities rose to $1,248,114, up from $1,019,120, reflecting a 22% increase[17]. - Long-term debt decreased to $403,923 from $658,392, a reduction of 39%[17]. - Total stockholders' equity increased to $6,320,879, up from $5,967,859, indicating a growth of 6%[17].

Financial Performance - Quarterly net income available to common shareholders was $13.1 million, or earnings per share (EPS) of $1.58, compared to $14.2 million, or $1.70 per share, in the previous quarter[1] - Net income for the fourth quarter of 2025 was $13,333 thousand, a decrease of 7.5% from $14,415 thousand in the same quarter of 2024[37] - Basic earnings per share for the year ended December 31, 2025, were $5.94, up from $5.20 in 2024, indicating a growth of 14.2%[37] Loan and Deposit Growth - Core deposits grew by $80.9 million, or 12.5% annualized, from the linked quarter, and $276.6 million, or 11.5%, from the fourth quarter of 2024[3] - Total loans increased by $38.6 million, or 4.6% annualized, from the previous quarter, and $261.4 million, or 8.4%, from the fourth quarter of 2024[3] - Total deposits reached $3,380,415 thousand as of December 31, 2025, an increase of 8.8% from $3,107,140 thousand a year prior[36] - Total gross loans and leases receivable increased to $3,375,227 thousand as of December 31, 2025, up from $3,113,850 thousand a year earlier, representing a growth of 8.43%[51] - Total period-end core deposits grew by $276.6 million, or 11.5%, to $2.673 billion, while the average rate paid decreased by 34 basis points to 2.64%[25] Interest Income and Margin - The net interest margin was 3.53%, down from 3.68% in the previous quarter, primarily due to non-accrual interest reversals[3] - Net interest income increased by $1.6 million, or 4.9%, to $34.8 million, with a 7.3% increase when excluding non-accrual interest activity[17] - Net interest income for the year ended December 31, 2025, was $136,690 thousand, an increase from $124,205 thousand in 2024 and $112,588 thousand in 2023[41] - The yield on average interest-earning assets decreased by 46 basis points to 6.38%, with a net interest margin decrease of 24 basis points to 3.53%[22] Asset Quality - Non-performing assets rose to $43.9 million, or 1.07% of total assets, primarily due to the downgrade of $20.4 million in commercial real estate loans[15] - Provision for credit losses was $1.9 million, up from $1.4 million in the previous quarter, reflecting net charge-offs and loan growth[7] - Non-accrual loans and leases increased to $43,855,000 as of December 31, 2025, from $28,367,000 a year earlier[48] - Net charge-offs for the three months ended December 31, 2025, were $2,545,000, up from $942,000 in the same period of 2024[49] Efficiency and Expenses - The efficiency ratio improved to 56.61% from 57.44% in the previous quarter, indicating enhanced operating efficiency[3] - Compensation expense increased by $1.6 million, or 10.4%, to $17.2 million, reflecting a rise in average FTEs and salary increases[30] - Efficiency ratio improved to 56.61% for the three months ended December 31, 2025, from 56.94% in 2024[47] Dividends and Shareholder Returns - The quarterly cash dividend was increased by 17% to $0.34 per share, marking the 14th consecutive annual increase[3] - The Company announced a quarterly cash dividend of $0.34 per share, representing a 17% increase over the previous quarter's dividend[28] - The company declared dividends of $0.29 per share for the fourth quarter of 2025, consistent with the previous quarter and an increase from $0.25 in the same quarter of 2024[37] Capital and Liquidity - Total assets increased to $4,081,887 thousand as of December 31, 2025, up from $3,853,215 thousand a year earlier, representing a growth of 5.9%[36] - Total liabilities increased to $3,710,302 thousand as of December 31, 2025, from $3,524,626 thousand a year earlier, reflecting a rise of 5.3%[36] - Total liquidity increased to $2,210,437 thousand as of December 31, 2025, compared to $1,909,248 thousand a year earlier, representing a growth of 15.77%[53] - Tangible common equity increased to $347,608 thousand as of December 31, 2025, compared to $304,685 thousand a year earlier, marking a growth of 14.05%[57]

Financial Performance - In the third quarter of fiscal 2026, GSI Technology reported net revenues of $6.1 million, a 12% increase year-over-year from $5.4 million in the same quarter of fiscal 2025[4]. - Gross margin for the third quarter of fiscal 2026 was 52.7%, down from 54.0% in the same quarter of the previous year, primarily due to product mix[4]. - Operating loss for the third quarter of fiscal 2026 was $(6.9) million, compared to an operating loss of $(4.1) million in the prior-year period[8]. - Net loss for the third quarter of fiscal 2026 was $(3.0) million, or $(0.09) per diluted share, an improvement from a net loss of $(4.0) million, or $(0.16) per diluted share, in the same quarter of fiscal 2025[9]. Cash and Assets - Cash and cash equivalents increased to $70.7 million as of December 31, 2025, up from $13.4 million at the end of March 2025, reflecting $46.9 million in net proceeds from a Registered Direct Offering[12]. - Total assets increased to $98,460 million as of December 31, 2025, compared to $43,317 million on March 31, 2025[22]. - Cash and cash equivalents rose significantly to $70,672 million from $13,434 million[22]. - Stockholders' equity improved to $83,620 million, up from $28,226 million[22]. - Current liabilities increased slightly to $7,613 million from $7,074 million[22]. - Long-term liabilities decreased to $7,227 million from $8,017 million[22]. - Accounts receivable decreased to $2,832 million from $3,169 million[22]. - Inventory remained relatively stable at $3,876 million compared to $3,891 million[22]. - Operating lease right-of-use assets decreased to $8,590 million from $9,547 million[22]. - Other current assets decreased to $1,933 million from $2,961 million[22]. - Other assets increased slightly to $9,654 million from $9,507 million[22]. Research and Development - Research and development expenses for the third quarter of fiscal 2026 were $7.5 million, up from $4.0 million in the prior-year period, driven by the development of new technologies[6]. - GSI Technology expects net revenues for the upcoming fiscal fourth quarter to be in the range of $5.7 million to $6.5 million, with gross margin anticipated to be approximately 54% to 56%[3]. - The company is advancing its APU roadmap and pursuing initial design wins for Gemini-II in defense-oriented programs and select commercial edge deployments[3]. - GSI Technology announced a proof-of-concept with G2 Tech and two government agencies, expecting roughly $1 million in government funding[6]. Sales Performance - Sales to KYEC were $1.1 million, representing 17.9% of net revenues, while sales to Nokia increased to $675,000, or 11.1% of net revenues, compared to the same period last year[5].

Financial Performance - Record Q2 revenues of $464 million, representing an 11% year-over-year growth[7] - Non-GAAP diluted earnings per share for Q2 reached a record $2.58, up 7% from the previous year[4] - Operating cash flow for Q2 was $62 million, reflecting strong operational performance[7] - The company raised its fiscal 2026 non-GAAP diluted earnings per share guidance to a range of $10.30 - $10.55, indicating a 10% - 13% year-over-year growth[8] - GAAP revenues for the three months ended December 31, 2024, were $419,820 million, while for the same period in 2025, revenues increased to $464,057 million, a growth of approximately 10.5%[20] - Total revenues for the six months ended December 31, 2024, were $763.827 million, with an operating income of $88.285 million, representing 11.6% of revenues[22] - For the same period in 2025, revenues increased to $848.680 million, with operating income of $91.868 million, accounting for 10.8% of revenues[22] - Non-GAAP net income for the six months ended December 31, 2024, was $62.521 million, with an EPS of $3.67[22] - In 2025, non-GAAP net income rose to $69.930 million, resulting in an EPS of $4.00[22] Segment Performance - The Security division reported a 15% increase in Q2 revenues year-over-year, with a focus on expanding recurring services revenue[5] - The Optoelectronics and Manufacturing division achieved 12% revenue growth in Q2, highlighting operational efficiency and customer demand[5] - The Security segment's GAAP revenues increased from $289,987 million in 2024 to $334,705 million in 2025, a growth of approximately 15.4%[20] - The Optoelectronics & Manufacturing segment's GAAP revenues increased from $100,743 million in 2024 to $112,552 million in 2025, a growth of about 11.5%[20] - The Healthcare segment's GAAP revenues decreased from $44,854 million in 2024 to $36,534 million in 2025, a decline of approximately 18.6%[20] - The Security segment generated revenues of $514.301 million in 2024, with an operating income of $82.909 million, which is 16.1% of revenues[22] - The Optoelectronics & Manufacturing segment reported revenues of $198.538 million in 2024, with an operating income of $22.891 million, representing 11.5% of revenues[22] - The Healthcare segment had revenues of $81.956 million in 2024, with an operating income of $2.522 million, accounting for 3.1% of revenues[22] Financial Position - The company's backlog stood at $1.8 billion as of December 31, 2025[4] - Total assets decreased from $2,522,241 million to $2,241,257 million, a decline of approximately 11.1%[18] - Total current assets decreased from $1,686,845 million to $1,422,861 million, a decline of about 15.6%[18] - Total liabilities increased from $1,676,751 million to $1,290,173 million, a decrease of approximately 23.1%[18] - Total stockholders' equity increased from $845,490 million to $951,084 million, an increase of about 12.5%[18] Operational Efficiency - Operating income as a percentage of revenues decreased from 13.8% in 2024 to 12.7% in 2025[20] - Non-GAAP operating income for the three months ended December 31, 2024, was $62,870 million, while in 2025, it increased to $65,147 million, reflecting a growth of about 3.6%[20] - Non-GAAP operating income for the Security segment was $90.096 million, or 17.5% of revenues, in 2024[22] - Non-GAAP operating income for the Optoelectronics & Manufacturing segment was $24.608 million, representing 12.4% of revenues in 2024[22] Strategic Initiatives - The company is well-positioned to capitalize on increasing industry demand and pursue strategic initiatives across key markets[3] - In November 2025, the company issued $575 million of convertible senior notes due in 2031 at an interest rate of 0.50%[5] - The company maintained its previous revenue guidance while increasing its earnings per share outlook[8] - The company incurred impairment, restructuring, and other charges of $1.393 million in 2024, which was 0.2% of revenues[22]

Contact: Richard L. Van Kirk, Chief Executive Officer (949) 769-3200 Exhibit 99.1 For Immediate Release PRO-DEX, INC. ANNOUNCES FISCAL 2026 SECOND QUARTER AND SIX-MONTH RESULTS IRVINE, CA, January 29, 2026 - PRO-DEX, INC. (NasdaqCM: PDEX) today announced financial results for its fiscal 2026 second quarter ended December 31, 2025. The Company also filed its Quarterly Report on Form 10-Q for the second quarter of fiscal year 2026 with the Securities and Exchange Commission today. Operating expenses (which in ...

Financial Performance - Consolidated net income for Q4 2025 was $122.0 million, or $10.99 per diluted share, showing a sequential growth from $108.2 million in Q3 2025[1] - Adjusted net income for Q4 2025 was $126.0 million, or $11.35 per diluted share, compared to $117.9 million in Q3 2025[1] - GAAP net income for Q4 2025 decreased by 19.7% to $122.0 million compared to $151.9 million in Q4 2024[28] - Adjusted net income for Q4 2025 remained flat at $126.0 million compared to Q4 2024[30] - Economic profit increased by 3.9% to $53.3 million for Q4 2025, driven by a decrease in the cost of capital[30] - Adjusted net income per diluted share rose by 11.6% to $11.35 in Q4 2025, compared to $10.17 in Q4 2024[30] - GAAP net income for the three months ended September 30, 2025, was $122.0 million, an increase from $108.2 million in the previous quarter[34] - Adjusted net income per diluted share increased to $11.35, compared to $10.28 in the previous quarter[34] - Economic profit for the quarter was $53.3 million, an increase from $43.0 million in the prior year, marking a growth of 24.3%[39] Revenue and Expenses - Total revenue for Q4 2025 was $579.9 million, an increase of 2.2% from $565.9 million in Q4 2024[59] - Adjusted revenue for the three months ended September 30, 2025, was $408.2 million, up from $405.1 million in the previous quarter[34] - Operating expenses increased by 33.5% ($40.7 million), primarily due to a 162.7% increase in general and administrative expenses, including a $35.8 million contingent loss related to legal matters[28] - Adjusted operating expenses for the quarter were $126.5 million, compared to $131.6 million in the same period last year, showing a decrease of 3.9%[39] Loan Portfolio and Collections - The average balance of the loan portfolio was $7.9 billion, with a consumer loan assignment unit volume of 71,731 and a dollar volume of $821.3 million[4] - Forecasted collection rates for Consumer Loans assigned in 2025 were 67.2%, with a slight decline from the initial forecast[7] - The forecasted net cash flows from the loan portfolio decreased by $34.2 million, or 0.3%, in Q4 2025[8] - Consumer Loan assignment volume decreased by 9.1% in unit volume and 11.3% in dollar volume during the fourth quarter of 2025 compared to the same period in 2024[23] - The forecasted collection percentage for dealer loans in 2025 is 65.7%, while for purchased loans it is 71.9%, reflecting variances of 0.2% and 0.4% respectively from initial forecasts[15] Dealer Activity - The company enrolled 1,207 new dealers, bringing the total to 9,863 active dealers during the quarter[4] - The number of active dealers decreased by 2.8% to 9,863 in the fourth quarter of 2025[24] - Consumer Loan unit volume from new active dealers increased by 8.1% to 2,954 in the fourth quarter of 2025[25] - The average volume per active dealer declined by 6.4% to 7.3 units in the fourth quarter of 2025[24] Legal and Contingent Losses - A contingent loss of $35.8 million was excluded from adjusted results due to previously disclosed legal matters[4] - The cumulative contingent losses recognized through Q4 2025 amounted to $82.6 million, with a potential cash payment of $75.5 million related to legal settlements[28] Capital and Debt - Average debt increased by 3.3% to $6,409.6 million in Q4 2025 from $6,202.5 million in Q4 2024[28] - Adjusted average capital for the three months ended September 30, 2025, was $535.0 million, compared to $539.4 million in the previous quarter[34] - Adjusted average capital for the quarter was $8,662.9 million, a slight decrease of 0.4% from $8,699.2 million in the previous quarter[39] Future Outlook - The company expects a long-term effective income tax rate increase to 25%, up from 23% previously used[36] - The company plans to host a webcast on January 29, 2026, to discuss its fourth quarter results[53] - The company emphasizes its role in providing financing solutions to consumers with poor credit histories, enabling vehicle ownership[55]

Financial Performance - Revenue for the first quarter of fiscal 2026 was $1,047.8 million, representing a 2.5% increase compared to $1,021.8 million in the same quarter last year[1] - GAAP diluted EPS decreased by 9.2% to $0.79, while non-GAAP diluted EPS increased by 1.0% to $1.04[1] - Net income for the three months ended December 27, 2025, was $179.1 million, down from $201.0 million in the prior year, representing a decrease of 10.9%[18] - Basic net income per share decreased to $0.80 from $0.87, while diluted net income per share also fell to $0.79 from $0.87[18] - Consolidated GAAP revenue increased to $1,047.8 million, up 2.7% from $1,021.8 million year-over-year[24] - Organic revenue, excluding COVID-19 related revenue, was $1,002.2 million, reflecting a 2.9% increase from $973.8 million in the prior year[24] - Non-GAAP net income was $235.5 million, compared to $238.6 million in the same quarter of 2024, resulting in a non-GAAP net income percentage of 22.5%[26] - Adjusted EBITDA for the quarter was $330.4 million, an increase from $326.0 million year-over-year[26] Revenue Breakdown - Diagnostics revenue was $464.4 million, a decrease of 1.3%, with organic diagnostics sales growing 1.2% excluding COVID-19 related revenue[5] - Breast Health revenue increased by 1.8% to $375.9 million, driven by strong sales of Endomagnetics products[5] - Surgical revenue grew by 8.7% to $180.8 million, primarily due to increased sales from the acquired Gynesonics business[5] - U.S. revenue increased by 2.0% to $773.5 million, while international revenue increased by 4.0% to $274.3 million[7] - Geographic revenues for the three months ended December 2025 show the United States at 73.8%, Europe at 15.4%, Asia-Pacific at 5.4%, and the rest of the world at 5.4%[37] - The United States revenue increased from 74.2% to 73.8% year-over-year, while Europe decreased from 14.6% to 15.4%[37] - Asia-Pacific revenue slightly increased from 5.9% to 5.4% year-over-year, indicating stable performance in the region[37] - The rest of the world revenue showed a minor decrease from 5.3% to 5.4% year-over-year, reflecting consistent market presence[37] - Overall, the company maintained a steady revenue distribution across geographic regions, with no significant fluctuations[37] Cash Flow and Financial Position - Cash flow from operations was $229.9 million, an increase of 21.4% compared to the prior year[5] - The company ended the quarter with cash and cash equivalents of $2.17 billion and an adjusted net leverage ratio of 0.3 times[7] - Cash and cash equivalents increased to $2,168.0 million as of December 27, 2025, compared to $1,959.5 million at the end of September 2025, reflecting a growth of 10.6%[20] - Total assets rose to $9,180.7 million as of December 27, 2025, up from $9,014.9 million at the end of September 2025, indicating an increase of 1.8%[20] - Total stockholders' equity increased to $5,245.1 million from $5,047.9 million, marking a growth of 3.9%[20] - The net leverage ratio as of December 27, 2025, was 0.3, indicating a strong balance sheet position[36] Expenses - Research and development expenses for the quarter were $60.5 million, slightly up from $60.3 million in the same quarter last year[18] - Selling and marketing expenses decreased to $154.9 million from $166.1 million, a reduction of 6.7%[18] - Capital expenditures for the quarter were $14.7 million, a decrease from $16.8 million in the same period last year[22] - The company plans to continue strategic investments, with $24.0 million allocated in the current quarter, compared to $6.0 million in the previous year[22] Merger and Acquisition - The company has scheduled a special meeting for stockholders to vote on a merger agreement with Blackstone and TPG[5] - Due to the merger agreement, the company is not providing annual or quarterly financial guidance for fiscal 2026[7] - Hologic is currently in the process of a proposed acquisition by affiliates of Blackstone Inc. and TPG Capital, with a Definitive Proxy Statement filed with the SEC[15] - The company faces various risks related to the proposed transaction, including regulatory approvals and potential impacts on stockholder relationships[14] Future Outlook - The performance metrics suggest a stable market environment for the company in the reported period[37] - The company continues to focus on geographic diversification to sustain revenue growth[37] - Future outlook may involve strategies to enhance revenue in underperforming regions like Asia-Pacific[37] - The company is likely to explore new product developments and market expansions to drive future growth[37]